In clinical practice, the intratumoral ratio of effector T cells versus regulatory T cells, especially the CD8+/Treg ratio, is a widely accepted prognostic index for many cancer types, including melanoma28, 29, 30, 31, 32, 33. Here, CD8A is linked to cancer.